Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThorpe Regulatory News (TFW)

Share Price Information for Thorpe (TFW)

Share Price is delayed by 15 minutes
Get Live Data
253.00    -5.00 (-1.94%)
Bid:
249.00
Ask:
255.00
Spread: 6.00 (2.41%)
Market Cap: £283.96m
TFW Live PriceLast checked at - London Stock Exchange

Intraday Thorpe Share Chart

Acquisition

2 Apr 2015 07:00

RNS Number : 2526J
Thorpe(F.W.) PLC
02 April 2015
 

F W Thorpe Plc

("F W Thorpe" or the "Company")

Acquisition

 

The Board of F W Thorpe Plc is pleased to announce the acquisition of 65% of the issued share capital of Dutch company, Lightronics Participaties B.V. ("Lightronics"), a specialist in lighting systems and controls for a range of different sectors.

 

The acquisition is expected to enhance earnings per share in the first full year of ownership and will complement the Company's existing technologies, presenting potential growth opportunities and synergies.

 

F W Thorpe will pay an initial consideration of €7.8m (circa £5.7m), with a fixed commitment that the remaining 35% of the issued share capital will be purchased from existing management between the third and sixth year anniversaries of the acquisition. As part of the transaction, the 35% held by management has been partially funded by F W Thorpe by the issue of a loan. The consideration for the remaining share capital will be based on the same earnings multiple as used to value the initial investment. The initial consideration will be funded via the Company's existing cash reserves and this is also the intention for the remaining consideration.

 

The current senior management team have agreed to remain with Lightronics and have signed new contracts to this effect.

 

About Lightronics

 

Lightronics specialises in the development, manufacture and supply of external and impact proof lighting, which includes street lighting, outdoor wall and ceiling luminaires as well as control systems. The majority of the revenues are derived from the Netherlands but there is an export presence in Germany, France, Belgium, Austria and Norway. Lightronics was originally established in 1946, is based in Waalwijk in the Netherlands and currently employs 45 people.

 

During its last financial year ended 31st December 2014, Lightronics achieved revenues of €13.9m and adjusted profit before tax of €1.4m. Net assets as at 31st December 2014 were €3.1m.

 

It is expected that Lightronics will make a minor contribution to the group's profits in 2014/15 and we expect the acquisition to be earnings enhancing in the 2015/16 financial year, being the first full year of ownership.

 

The addition of Lightronics will further develop F W Thorpe's sales presence in Europe. This will enable the group to build on the existing success of Lightronics by introducing F W Thorpe's product portfolio to new territories and further developing existing areas in mainland Europe where F W Thorpe already derives revenues.

 

Chairman, Andrew Thorpe commented:

 

"I would like to welcome Lightronics to the F W Thorpe group. This acquisition enables F W Thorpe to widen its distribution of products and technology in Europe as well as build upon what has been a consistently successful business in its own right for a number of years.

 

We are excited by this opportunity and are confident that this acquisition will generate further value for our shareholders."

 

For further information please contact: 

 

F W Thorpe Plc

Andrew Thorpe - Chairman Tel: 01527 583200

Craig Muncaster - Financial Director Tel: 01527 583200

 

N+1 Singer - Nominated Adviser

Richard Lindley / James White Tel: 020 7496 3000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQZMGGDRMRGKZM
Date   Source Headline
7th May 202610:24 amRNSTransaction in Own Shares
6th May 20269:45 amRNSTransaction in Own Shares
7th Apr 202610:22 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 202610:09 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSInterim Results
7th Jan 20262:51 pmRNSHolding(s) in Company
24th Dec 20259:09 amRNSTransaction in Own Shares
24th Dec 20259:09 amRNSTransaction in Own Shares
23rd Dec 20258:51 amRNSTransaction in Own Shares
23rd Dec 20258:51 amRNSTransaction in Own Shares
26th Nov 20259:04 amRNSPDMR Dealing
21st Nov 202511:13 amRNSResult of AGM
20th Nov 20253:15 pmRNSAGM Statement
20th Oct 20256:14 pmRNSHolding(s) in Company
20th Oct 202510:26 amRNSTransaction in Own Shares
9th Oct 202510:19 amRNSTransaction in Own Shares
8th Oct 202510:07 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSFinal Results
18th Jun 20254:40 pmRNSTransaction in Own Shares
30th May 202511:12 amRNSTransaction in Own Shares
23rd Apr 20259:45 amRNSTransaction in Own Shares
7th Apr 20258:20 amRNSTransaction in Own Shares
2nd Apr 20259:01 amRNSTransaction in Own Shares
1st Apr 20258:42 amRNSTransaction in Own Shares
27th Mar 20258:07 amRNSTransaction in Own Shares
21st Mar 20258:55 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSInterim Results
3rd Dec 202410:00 amRNSGrant of Options
22nd Nov 20243:36 pmRNSResult of AGM
21st Nov 20243:15 pmRNSAGM Statement
30th Oct 20243:25 pmRNSPDMR Dealing
3rd Oct 20247:00 amRNSFinal Results
15th Jul 20244:30 pmRNSExercise of Options, Treasury Shares and TVR
1st Jul 20244:46 pmRNSExercise of Options, Treasury Shares and TVR
31st May 202410:30 amRNSGrant of Options
31st May 202410:00 amRNSExercise of Options, Treasury Shares and TVR
23rd May 202410:00 amRNSDirectorate Changes
23rd Apr 20244:25 pmRNSPDMR & PCA Dealing
23rd Apr 202412:30 pmRNSResult of General Meeting
22nd Mar 202412:30 pmRNSNotice of GM
14th Mar 20247:00 amRNSInterim Results
16th Jan 202410:00 amRNSDirectorate Change
11th Dec 202310:00 amRNSExercise of Options, Treasury Shares and TVR
16th Nov 20235:21 pmRNSResult of AGM
16th Nov 20233:15 pmRNSAGM Statement
12th Oct 20237:00 amRNSFinal Results
4th Jul 20231:15 pmRNSDirectorate Changes
20th Apr 20234:02 pmRNSPDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.